Bearish flow noted in GSK (GSK) Pharma with 5,611 puts trading, or 3x expected. Most active are Mar-25 36.5 puts and 3/14 weekly 39.5 calls, with total volume in those strikes near 6,100 contracts.

GSK has revealed the data it hopes will allow a return to the US market for Blenrep, which was the first BCMA-targeting drug to launch there, but was withdrawn from sale after it failed a ...

DUBLIN--(BUSINESS WIRE)--The "Enterprise Tech Ecosystem Series: GSK plc 2024" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into company's tech ...

GSK licensed the drug from longstanding partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

the Michigan Boating Facility Finder (MiBFF), with an interactive map and list option for boaters to scroll through more than 1,000 boat launch sites. The website includes information on type of ...

Visitors to pressrepublican.com are going to witness major improvements to the site over the next few months ... subscribers — will need to sign up for this service. Our old Breaking News ...

He said: "These maps paint an incredibly troubling picture of what is now happening in some areas of the country. "These are just a handful of many places I could have chosen in England today ...

This public frenzy has unlocked a flood of investment from venture capitalists—funding for longevity startups is up by 75% over the ... his first venture, which GSK bought in 2008, to develop ...